Extension Study of the Safety and Efficacy of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Summary

The primary objective of this study is to evaluate the safety and tolerability of long term (6 months) armodafinil treatment as adjunctive therapy to mood-stabilizing medications in adults with bipolar I disorder.

Timeline

Start

2010-04-30

Primary completion

2013-10-31

Completion

2013-10-31

Outcome

Outcome not reported

Stopped (Business): “Business decision related to efficacy rather than tolerability limitations, not stopped for any safety reasons.”

Drugs

Indications